NLM Digital Collections

Search

Start Over Subjects Hypoglycemic Agents -- therapeutic use ✖Remove constraint Subjects: Hypoglycemic Agents -- therapeutic use Publication Year 2015 to 2016 ✖Remove constraint Publication Year: <span class="from" data-blrl-begin="2015">2015</span> to <span class="to" data-blrl-end="2016">2016</span>

1. 2014 diabetes health care cost and utilization report

Publication:
Washington, DC, : Health Care Cost Institute, June 2016
Subject(s):
Diabetes Mellitus -- economics
Health Care Costs -- statistics & numerical data
Health Care Costs -- trends
Health Expenditures -- statistics & numerical data
Health Expenditures -- trends
Health Services -- utilization
Adolescent
Adult
Child
Diabetes Mellitus -- therapy
Forecasting
Health Benefit Plans, Employee
Hypoglycemic Agents -- therapeutic use
Infant
Middle Aged
Prescription Drugs -- therapeutic use
Sex Factors
Young Adult
Humans
United States

2. Insulin degludec (Tresiba??, Novo Nordisk A/S) for the treatment of diabetes: effectiveness, value, and value-based price benchmarks : final report

Author(s):
Tice, Jeffrey A., author
Ollendorf, Daniel A., author
Chapman, Rick, author
Shore, Karen K., author
Weissberg, Jed, author
Pearson, Steven D., author
Publication:
[Boston, MA] : Institute for Clinical and Economic Review, March 14, 2016
Subject(s):
Blood Glucose -- drug effects
Diabetes Mellitus, Type 1 -- drug therapy
Diabetes Mellitus, Type 2 -- drug therapy
Hypoglycemia -- prevention & control
Hypoglycemic Agents -- therapeutic use
Insulin, Long-Acting -- administration & dosage
Insulin, Long-Acting -- therapeutic use
Blood Glucose -- metabolism
Cost-Benefit Analysis
Diabetes Mellitus, Type 1 -- blood
Diabetes Mellitus, Type 1 -- complications
Diabetes Mellitus, Type 2 -- blood
Diabetes Mellitus, Type 2 -- complications
Hypoglycemia -- blood
Hypoglycemia -- chemically induced
Hypoglycemic Agents -- administration & dosage
Insulin -- adverse effects
Severity of Illness Index
Humans
United States